Molecular tumour board in gastrointestinal cancers

ESMO Open shared a post on X about a recent paper by L. Boscolo Bielo et al. published in ESMO Open:

“Retrospective analysis of MTB impact on the care of patients with GI tumors at The European Institute of Oncology just published in ESMO Open.

Among 192 patients discussed at the MTB, 31 (17.7%) were recommended molecularly guided treatment options, experiencing longer rwPFS.”